ReviewMemo2017
New diagnostic tools for breast cancer.
Review in Memo, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Contrast agent-free breast MRI : Advantages and potential disadvantages].Der Radiologe · 2019Pooled it
- A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial.European radiology · 2019Trial
- Review of Artificial Intelligence Techniques for Breast Cancer Detection with Different Modalities: Mammography, Ultrasound, and Thermography Images.Bioengineering (Basel, Switzerland) · 2025Review
- Envisioning Clinical Management of Breast Cancer: a Comprehensive Review.Current drug discovery technologies · 2025Review
- Radiomics Integration of Mammography and DCE-MRI for Predicting Molecular Subtypes in Breast Cancer Patients.Breast cancer (Dove Medical Press) · 2025Article
- DWI in the Differentiation of Malignant and Benign Breast Lesions Presenting with Non-Mass Enhancement on CE-MRI.Cancers · 2024Article
- Systematic Meta-Analysis of Computer-Aided Detection of Breast Cancer Using Hyperspectral Imaging.Bioengineering (Basel, Switzerland) · 2024Review
- The Utility of Contrast-Enhanced Mammography in the Evaluation of Bloody Nipple Discharge-A Multicenter Study in the Asian Population.Diagnostics (Basel, Switzerland) · 2024Article
- Harnessing the nutriceutics in early-stage breast cancer: mechanisms, combinational therapy, and drug delivery.Journal of nanobiotechnology · 2024Review
- A risk prediction stratification for non-mass breast lesions, combining clinical characteristics and imaging features on ultrasound, mammography, and MRI.Frontiers in oncology · 2024Article
- [Hsa-miR-148a-3p promotes malignant behavior of breast cancer cells by downregulating DUSP1].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023Article
- MicroRNA-26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer.Oncology letters · 2021Article
- Pendant breast immobilization and positioning in photoacoustic tomographic imaging.Photoacoustics · 2021Article
- [Artificial intelligence in breast imaging : Areas of application from a clinical perspective].Der Radiologe · 2021Review
- A Comparative Assessment of MR BI-RADS 4 Breast Lesions With Kaiser Score and Apparent Diffusion Coefficient Value.Frontiers in oncology · 2021Article
- Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.Journal of magnetic resonance imaging : JMRI · 2020Article
- Radiomics for Tumor Characterization in Breast Cancer Patients: A Feasibility Study Comparing Contrast-Enhanced Mammography and Magnetic Resonance Imaging.Diagnostics (Basel, Switzerland) · 2020Article
- MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3.Thoracic cancer · 2020Article
- Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.The oncologist · 2020Review
- Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.Breast cancer research : BCR · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Imaging plays a major role in the diagnosis, treatment, and follow-up of breast cancer. Findings that require further assessment will be detected both at screening and curative mammography. Most findings that are further worked up tend to yield benign diagnoses. Consequently, there is an ongoing search for new tools to reduce recalls and unnecessary biopsies while maintaining or improving cancer detection rates. The clinically most promising methods in this respect are described and discussed in this review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.